Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Amanda LC Chen

Biographic Data

ID7180385
NAMEAmanda LC Chen
GIVEN NAMESAmanda LC
FAMILY NAMEChen
SIGNATURECHEN A L
AFFILIATIONSChang Jung Christian University
VERIFIEDNo
TOTAL WORKS5
TOTAL CITATIONS0
AUTHOR COUNT5
EDITOR COUNT0
FIRST PUBLICATION YEAR2008
LATEST PUBLICATION YEAR2012
H-INDEX0
  • The Addictive Brain

    Kenneth Blum, Amanda LC Chen et al.•ARTICLE•Journal of Psychoactive Drugs•2012

    This article will touch on theories, scientific research and conjecture about the evolutionary genetics of the brain function and the impact of genetic variants called polymorphisms on drug-seeking behavior. It will cover the neurological basis of pleasure-seeking and addiction, which affects multitudes in a global atmosphere where people are seeking "pleasure states"

  • Early Intervention of Intravenous KB220IV- Neuroadaptagen Amino-Acid Therapy (Naat)TM Improves Behavioral Outcomes in a Residential Addiction Treatment Program

    Merlene Miller, Amanda LC Chen et al.•ARTICLE•Journal of Psychoactive Drugs•2012

    Substance use disorders (SUD) are inheritable and the culprit is hypodopaminergic function regulated by reward genes. We evaluated a natural dopaminergic agonist; KB220 intravenous (IV) and oral variants, to improve dopaminergic function in SUD. Our pilot experiment found a significant reduction of chronic symptoms, measured by the Chronic Abstinence Symptom Severity (CASS) Scale. The combined group (IV and oral) did significantly better than the…

  • Generational Association Studies of Dopaminergic Genes in Reward Deficiency Syndrome (RDS) Subjects

    Open Access•Kenneth Blum, Amanda LC Chen et al.•ARTICLE•International Journal of…•2011

    Although our sample size was limited, and linkage analysis is necessary, the results support the putative role of dopaminergic polymorphisms in RDS behaviors. This study shows the importance of a nonspecific RDS phenotype and informs an understanding of how evaluating single subset behaviors of RDS may lead to spurious results. Utilization of a nonspecific "reward" phenotype may be a paradigm shift in future association and linkage studies involv…

  • Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen

    Thomas J H Chen, Kenneth Blum et al.•ARTICLE•Journal of Psychoactive Drugs•2011

    This document presents evidence supporting the role of the KB220/KB220Z neuroadaptagens consisting of amino-acid neurotransmitter precursors and enkephalinase-catecholamine-methyl-transferase (COMT) inhibition therapy called Neuroadaptagen Amino Acid Therapy (NAAT) in brain reward function. It is becoming increasingly clear that this novel formulation is the first neuroadaptagen known to activate the brain reward circuitry. Ongoing research repea…

  • Hypothesizing that Marijuana Smokers are at a Significantly Lower Risk of Carcinogenicity Relative to Tobacco-Non-Marijuana Smokers

    Amanda LC Chen, Amanda L C Chen et al.•ARTICLE•Journal of Psychoactive Drugs•2008

    A hypothetical link between marijuana smoking and cancer has been established based on a number of misleading assumptions. However, recent studies tend to suggest, if anything, an inverse association between marijuana use and cancers. To test the hypothesis that marijuana smoking significantly lowers the risk of developing cancer in humans, we analyzed published data from a prospective cohort study on cancer incidence among nonsmokers (NS), marij…

No prominent works on this page.

  • Hypothesizing that Marijuana Smokers are at a Significantly Lower Risk of Carcinogenicity Relative to Tobacco-Non-Marijuana Smokers

    Amanda LC Chen, Amanda L C Chen et al.•ARTICLE•Journal of Psychoactive Drugs•2008

    A hypothetical link between marijuana smoking and cancer has been established based on a number of misleading assumptions. However, recent studies tend to suggest, if anything, an inverse association between marijuana use and cancers. To test the hypothesis that marijuana smoking significantly lowers the risk of developing cancer in humans, we analyzed published data from a prospective cohort study on cancer incidence among nonsmokers (NS), marij…

  • Generational Association Studies of Dopaminergic Genes in Reward Deficiency Syndrome (RDS) Subjects

    Open Access•Kenneth Blum, Amanda LC Chen et al.•ARTICLE•International Journal of…•2011

    Although our sample size was limited, and linkage analysis is necessary, the results support the putative role of dopaminergic polymorphisms in RDS behaviors. This study shows the importance of a nonspecific RDS phenotype and informs an understanding of how evaluating single subset behaviors of RDS may lead to spurious results. Utilization of a nonspecific "reward" phenotype may be a paradigm shift in future association and linkage studies involv…

  • Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen

    Thomas J H Chen, Kenneth Blum et al.•ARTICLE•Journal of Psychoactive Drugs•2011

    This document presents evidence supporting the role of the KB220/KB220Z neuroadaptagens consisting of amino-acid neurotransmitter precursors and enkephalinase-catecholamine-methyl-transferase (COMT) inhibition therapy called Neuroadaptagen Amino Acid Therapy (NAAT) in brain reward function. It is becoming increasingly clear that this novel formulation is the first neuroadaptagen known to activate the brain reward circuitry. Ongoing research repea…

  • The Addictive Brain

    Kenneth Blum, Amanda LC Chen et al.•ARTICLE•Journal of Psychoactive Drugs•2012

    This article will touch on theories, scientific research and conjecture about the evolutionary genetics of the brain function and the impact of genetic variants called polymorphisms on drug-seeking behavior. It will cover the neurological basis of pleasure-seeking and addiction, which affects multitudes in a global atmosphere where people are seeking "pleasure states"

  • Early Intervention of Intravenous KB220IV- Neuroadaptagen Amino-Acid Therapy (Naat)TM Improves Behavioral Outcomes in a Residential Addiction Treatment Program

    Merlene Miller, Amanda LC Chen et al.•ARTICLE•Journal of Psychoactive Drugs•2012

    Substance use disorders (SUD) are inheritable and the culprit is hypodopaminergic function regulated by reward genes. We evaluated a natural dopaminergic agonist; KB220 intravenous (IV) and oral variants, to improve dopaminergic function in SUD. Our pilot experiment found a significant reduction of chronic symptoms, measured by the Chronic Abstinence Symptom Severity (CASS) Scale. The combined group (IV and oral) did significantly better than the…

Addiction (4 works) · Dopamine (4 works) · Medicine (4 works) · Psychiatry (4 works) · Attention Deficit Hyperactivity Disorder (3 works) · Dopaminergic (3 works) · Neuroscience (3 works) · Neurotransmitter Receptor Influence on Behavior (3 works) · Psychology (3 works) · Brain stimulation reward (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae